← FDA Drug Approvals (Drugs@FDA)
BORTEZOMIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2026-01-06
Drug application
- FDA Application #
ANDA219167- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BORTEZOMIB
- Generic name
- BORTEZOMIB
- Active ingredients
- BORTEZOMIB
- Dosage form
- POWDER
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- GLAND
- Manufacturer
- Gland Pharma Limited
- First approval
- 2026-01-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown